Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults - a Randomized Placebo-controlled Pilot Study

NCT02057263 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02057263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02057263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults - a Randomized Placebo-controlled Pilot Study
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2014
Completion date
February 29, 2016
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b